MENU
BBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BridgeBio Pharma (BBIO) Earnings Date & Reports

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases... Show more

A.I. Advisor
published Earnings

BBIO is expected to report earnings to fall 34.84% to -91 cents per share on May 01

BridgeBio Pharma BBIO Stock Earnings Reports
Q1'25
Est.
$-0.91
Q4'24
Missed
by $0.27
Q3'24
Beat
by $0.13
Q2'24
Beat
by $0.41
Q1'24
Beat
by $0.72
The last earnings report on February 20 showed earnings per share of -139 cents, missing the estimate of -112 cents. With 888.42K shares outstanding, the current market capitalization sits at 6.57B.
View a ticker or compare two or three
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3160 Porter Drive
Phone
+1 650 391-9740
Employees
556
Web
https://www.bridgebio.com